Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?
about
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceNew targets for therapy in breast cancer: mammalian target of rapamycin (mTOR) antagonistsDifferential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells.Neuroprotective Effects of Salidroside in the MPTP Mouse Model of Parkinson's Disease: Involvement of the PI3K/Akt/GSK3β PathwayPI3K activation is associated with intracellular sodium/iodide symporter protein expression in breast cancerSynergistic effect of ERK inhibition on tetrandrine-induced apoptosis in A549 human lung carcinoma cells.Detecting phenotype-specific interactions between biological processes from microarray data and annotations.Exploring the role of two interacting phosphoinositide 3-kinases of Haemonchus contortus.Coupling in vitro and in vivo paradigm reveals a dose dependent inhibition of angiogenesis followed by initiation of autophagy by C6-ceramide.Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression.mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokineLuminal-B breast cancer and novel therapeutic targets.Activation of Robo1 signaling of breast cancer cells by Slit2 from stromal fibroblast restrains tumorigenesis via blocking PI3K/Akt/β-catenin pathway.PI3K/AKT inhibition induces caspase-dependent apoptosis in HTLV-1-transformed cells.Induction of methionine adenosyltransferase 2A in tamoxifen-resistant breast cancer cells.Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia.Phosphoinositide 3-kinases in cell migration.Metabolic consequences of treatment with AKT inhibitor perifosine in breast cancer cells.NOTCH and phosphatidylinositide 3-kinase/phosphatase and tensin homolog deleted on chromosome ten/AKT/mammalian target of rapamycin (mTOR) signaling in T-cell development and T-cell acute lymphoblastic leukemia.Impact of diet on breast cancer risk: a review of experimental and observational studies.Calcium regulation of keratinocyte differentiation.Human activated macrophages and hypoxia: a comprehensive review of the literature.Revisiting the estrogen receptor pathway and its role in endocrine therapy for postmenopausal women with estrogen receptor-positive metastatic breast cancer.Role of Class III phosphoinositide 3-kinase in the brain development: possible involvement in specific learning disorders.PI3K signaling in Leishmania infections.EGFR mediates docetaxel resistance in human castration-resistant prostate cancer through the Akt-dependent expression of ABCB1 (MDR1).Combined effect of sCD40L and PI3K siRNA on transplanted tumours growth and microenvironment in nude mice with gastric cancer.Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells.Expression profiling of the estrogen responsive genes in response to phytoestrogens using a customized DNA microarray.Alternative phospholipase D/mTOR survival signal in human breast cancer cells.Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopyLoss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors.Targeting PDK1 for Chemosensitization of Cancer Cells.Regulation of glycogen synthase kinase 3 in human platelets: a possible role in platelet function?Comprehensive molecular biomarker identification in breast cancer brain metastases.Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer.Characterization of Apoptosis in a Breast Cancer Cell Line after IL-10 SilencingBiosynthetic pathway for furanosteroid demethoxyviridin and identification of an unusual pregnane side-chain cleavage.Targeting Nicotinamide N-Methyltransferase and miR-449a in EGFR-TKI-Resistant Non-Small-Cell Lung Cancer Cells.Profiling of phosphatidylinositol 3-kinase (PI3K) proteins in insulin signaling pathway.
P2860
Q24645668-00A8CD98-DE27-4EC2-8700-4FD3A5A908E4Q24806542-A4A9D267-328C-4602-93BD-E85384040C7AQ24813382-EC29A35C-97BF-4034-8025-470DDB478FB1Q28390865-B8C000A8-F722-4213-8050-42280CE5EA6EQ33291674-7A93752A-7A15-4104-9518-6377B3B8394EQ33569013-17451377-682C-4681-AA1C-047B6D8960D7Q34252449-4B3F71FC-D703-4A1C-8DA5-7E1C41CC3DA5Q34517777-25CE102D-3328-421B-9DAE-AA87C9E3072DQ35022529-43719414-493C-48F7-BF50-CC6ECD8A31E9Q35094456-A985D151-0AF1-4160-AE7C-C185256A014EQ35609031-B291F7C6-690C-4C5A-95CA-0E8E3A2AA629Q35889534-900125F5-23B8-4E2D-90CC-EC2038FAF6AFQ36243638-18180C17-48A1-4C9F-AFB4-358FC951D94AQ36358632-00742BFD-01C6-4EE7-9D57-65C535E019D0Q37046483-08115105-D9CA-45E4-86E2-E7202C55BC71Q37109227-FD190DF7-47AC-47A6-B995-80E73AEE6A64Q37340915-3F653090-08B1-4944-876F-54075BCB3AD0Q37576912-EF037F9E-FEA0-4322-A287-A033E90F9286Q37861191-8F81E3B3-6E77-424B-B289-0504B8B67713Q38049353-62F17E97-E299-4891-BE24-F9B8BEDB0209Q38059209-9655F541-FBC8-474E-BEEE-1579CE06A919Q38359794-C1D84FCA-B491-4717-AE59-51DEDEC921D5Q38374560-DB46AE46-C81E-4D3A-B298-42C484FA197AQ38823281-4EFD6487-4EE0-4F13-B089-5B9D96A60A9CQ38953117-0FA3F657-AA66-4E9B-9A96-7CDC36821353Q38989173-B3454EAC-CE95-41C4-9C35-0D44AF8F5A57Q39596491-C06DF3A8-BB01-48BA-B758-A2376F2162F1Q39618112-D07204CB-FE27-4617-9868-3E708B45D493Q40448493-C9AB682D-9EF0-4268-A5B1-8D3A7D144CDCQ40484574-0C460B65-76CE-475E-97C8-0D131F7D0BE2Q41939336-071E691C-6C20-4667-8F6B-BEFD059C3B0CQ42441080-48B50D89-FB4E-4DCD-B0C5-E25D5BED877CQ43276810-576E4CC8-5D64-40FA-9BE5-7DAC34351269Q44612512-031CB377-1D2C-4077-9667-5C83CB603CE7Q47098306-EC46EE80-A227-488C-B581-6BE2E52B155AQ51116483-F76DDC44-2EEA-48C0-9C31-4BC7C3563B46Q52628573-B9A1F812-EE64-4724-A18C-B9B3769A1B0CQ54111180-3C8DAD6D-9F5B-4160-AA42-127296811068Q54977358-2A6CD18E-1360-4E34-A6C4-9FFF6F2E1462Q55068315-0B4C7A7D-6932-448C-99F1-1705C723F86D
P2860
Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?
@ast
Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?
@en
Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?
@nl
type
label
Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?
@ast
Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?
@en
Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?
@nl
prefLabel
Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?
@ast
Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?
@en
Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?
@nl
P2860
P921
P3181
P356
P1476
Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?
@en
P2093
P2860
P2888
P304
P3181
P356
10.1186/BCR312
P407
P577
2001-06-28T00:00:00Z
P5875
P6179
1023379228